PHOSPHATIDYLGLYCEROL DEPENDENT PROTEIN TRANSLOCATION ACROSS THE ESCHERICHIA-COLI INNER MEMBRANE IS INHIBITED BY THE ANTICANCER DRUG DOXORUBICIN - EVIDENCE FOR AN ELECTROSTATIC INTERACTION BETWEEN THE SIGNAL SEQUENCE AND PHOSPHATIDYLGLYCEROL
Da. Phoenix et al., PHOSPHATIDYLGLYCEROL DEPENDENT PROTEIN TRANSLOCATION ACROSS THE ESCHERICHIA-COLI INNER MEMBRANE IS INHIBITED BY THE ANTICANCER DRUG DOXORUBICIN - EVIDENCE FOR AN ELECTROSTATIC INTERACTION BETWEEN THE SIGNAL SEQUENCE AND PHOSPHATIDYLGLYCEROL, FEBS letters, 324(1), 1993, pp. 113-116
OmpF-Lpp, a model secretory protein, requires both a positively charge
d signal sequence and phosphatidylglycerol (PG) for efficient transloc
ation across the E coli inner membrane. Modification of the signal seq
uence can, however, remove both these prerequisites for translocation
providing OmpF-Lpp mutants which undergo either PG and charge dependen
t or PG and charge independent translocation. Here we show that positi
vely charged membrane interactive compounds (polylysine & doxorubicin)
are able to inhibit PG dependent translocation of the OmpF-Lpp signal
sequence mutants but not PG independent translocation. Doxorubicin is
also shown to bind more efficiently to liposomes containing increased
levels of anionic lipid indicating that in these assays it may be inh
ibiting translocation by preventing electrostatic interaction between
the anionic lipid head group and the positively charged signal sequenc
es.